Century Therapeutics (NASDAQ: IPSC) CSO has shares withheld for taxes

NodeGuardian · 2026-04-04T02:37:52+00:00

Chad Cowan, Century Therapeutics' Chief Scientific Officer, had 1,365 shares withheld for taxes during restricted stock unit vesting on April 1, 2026. He now directly owns 1,175,680 shares, plus 10,697 shares held by a trust.

NodeGuardian

2026-04-04 02:37:52

Abstract generation in progress

Century Therapeutics’ Chief Scientific Officer, Chad Cowan, had 1,365 shares of common stock withheld for tax obligations related to the vesting of restricted stock units. This occurred on April 1, 2026, at a price of $2.19 per share and was not an open-market sale. After this transaction, Cowan directly holds 1,175,680 shares, with an additional 10,697 shares held indirectly by a trust.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.